GNAS1 codes for a part of the a-stimulatory subunit (Gsa) of the G protein. Mutation of GNAS1 has been frequently found in myxoid soft tissues, however, in gastrointestinal tumors, little is known about the mutation status of GNAS1. The aim of the study was to analyze the occurrence of GNAS1 mutations indifferent gastrointestinal, gastroenteropancreatic neuroendocrine tumors (GEP-NETs) and colorectal tumors. Mutation status of GNAS1 exon 8 was analyzed in one hundred thirty-five formalin-fixed, paraffin-embedded (FFPE) gastrointestinal tumor samples including 45 tubular-villous adenomas, 11 tubular adenomas, 6 villousadenomas, 10 hyperplastic gastric polyps, 31 GEP-NETs and 32 colorectal adenocarcinomas by using polymerase chain reaction (P...
Abstract Background Gastric cancer, which is also known as stomach cancer, can be influenced by both...
<p>Representative chromatograms (left) and pyrograms (right) of GNAS wild-type, GNAS R201C, and GNAS...
International audienceBackground: Forty percent of somatotroph tumors harbor recurrent activating GN...
The purpose of this study is to determine the genetic frequency of GNAS activating mutations in colo...
Somatically acquired, activating mutations of GNAS, the gene encoding the stimulatory G-protein Gsal...
Activating mutations in GNAS are important in the development of a range of neoplasms, including a s...
Background: The molecular basis for the development of appendiceal mucinous tumours, which can be a ...
International audienceBACKGROUND & AIMS: Mosaic G-protein alpha-subunit (GNAS)-activating mutations ...
Intraductal papillary neoplasms of the bile duct (IPN-Bs) share clinicopathologic features with intr...
Background: Mutations activating the α subunit of heterotrimeric Gs protein are associated with a nu...
Review on GNAS (GNAS complex locus), with data on DNA, on the protein encoded, and where the gene is...
Abstract Background A large number of novel, rare, and uncharacterized mutations in Tumors including...
To clarify the genetic mutations associated with intraductal papillary mucinous neoplasms (IPMN) and...
This review summarizes the pathogenetic role of naturally occurring mutations of G protein genes in ...
<div><p>Background</p><p>To clarify the genetic mutations associated with intraductal papillary muci...
Abstract Background Gastric cancer, which is also known as stomach cancer, can be influenced by both...
<p>Representative chromatograms (left) and pyrograms (right) of GNAS wild-type, GNAS R201C, and GNAS...
International audienceBackground: Forty percent of somatotroph tumors harbor recurrent activating GN...
The purpose of this study is to determine the genetic frequency of GNAS activating mutations in colo...
Somatically acquired, activating mutations of GNAS, the gene encoding the stimulatory G-protein Gsal...
Activating mutations in GNAS are important in the development of a range of neoplasms, including a s...
Background: The molecular basis for the development of appendiceal mucinous tumours, which can be a ...
International audienceBACKGROUND & AIMS: Mosaic G-protein alpha-subunit (GNAS)-activating mutations ...
Intraductal papillary neoplasms of the bile duct (IPN-Bs) share clinicopathologic features with intr...
Background: Mutations activating the α subunit of heterotrimeric Gs protein are associated with a nu...
Review on GNAS (GNAS complex locus), with data on DNA, on the protein encoded, and where the gene is...
Abstract Background A large number of novel, rare, and uncharacterized mutations in Tumors including...
To clarify the genetic mutations associated with intraductal papillary mucinous neoplasms (IPMN) and...
This review summarizes the pathogenetic role of naturally occurring mutations of G protein genes in ...
<div><p>Background</p><p>To clarify the genetic mutations associated with intraductal papillary muci...
Abstract Background Gastric cancer, which is also known as stomach cancer, can be influenced by both...
<p>Representative chromatograms (left) and pyrograms (right) of GNAS wild-type, GNAS R201C, and GNAS...
International audienceBackground: Forty percent of somatotroph tumors harbor recurrent activating GN...